Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 14 announcements

Share price
₹863.75
Market cap
₹16,978 Cr
Revenue (annual)
₹7,345 Cr
Net profit (annual)
₹674.8 Cr
P/E (TTM)
24.5×Sector 50.4×
Promoter holding
69.87%+0.13% QoQ
FII holding
4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:37 IST NSE
Business Update

Alembic Pharmaceuticals Business Update

Alembic Pharmaceuticals completed an unannounced USFDA onsite inspection at its Vadodara Bioequivalence Facility. The inspection concluded with zero Form 483 observations, a positive regulatory signal.